dorsaVi expands into clinical and elite sporting markets in the US

dorsaVi expands into clinical and elite sporting markets in the US

Following the appointment of dorsaVi’s US President, John Kowalczyk, and a highly experienced sales and marketing team, the Company has made good early progress in the United States.

Most significantly, dorsaVi has commenced the launch of ViMove, its clinical product, following 510K clearance by the US Food and Drug Administration (FDA).

Image 8dorsaVi has also introduced ViPerform, the company’s product for the elite sports market, to the US recently and has Metro Orthopaedics and Sports Therapy (MOST) in Silver Spring, Maryland, as one of the first to integrate the technology into their practice.

MOST is an internally recognised sports medicine, spine and performance practice which provides comprehensive sports training and injury recovery programs for elite athletes and members of the general public.

dorsaVi US President John Kowalczyk said, “Metro Orthopaedics and Sports Therapy, a well known and highly regarded healthcare practice, will use ViPerform to help maximise athletes’ potential and use the device’s objective data capabilities for research projects.”

Request Info